← Back to Clinical Trials
Recruiting NCT04599270

NCT04599270 Efficiency of Prevention Program Dedicated to Addictive Behaviors (PREVENTURE) of Vulnerable Teenagers

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT04599270
Status Recruiting
Phase
Sponsor University Hospital, Brest
Condition Addiction, Alcohol
Study Type INTERVENTIONAL
Enrollment 700 participants
Start Date 2021-10-01
Primary Completion 2026-10-01

Eligibility & Interventions

Sex All sexes
Min Age 14 Years
Max Age 17 Years
Study Type INTERVENTIONAL
Interventions
PREVENTURE ProgramRoutine care

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 700 participants in total. It began in 2021-10-01 with a primary completion date of 2026-10-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

At the age of 17, in Brittany, 94.9% of adolescents have experimented alcohol consumption 78.1% within a month and 25.5% report repeated episodes of Intensive Punctual Alcohol. Among the potential explanatory factors of this worrying epidemiology, social and cultural factors induce a social valuation of alcohol consumption and drunkenness. There are also individual vulnerability factors, particularly important in adolescence between experimentation and the transition to regular use or even to alcohol use disorders. Despite the extent of the damage, there is currently little reliable data on effective primary prevention strategies for dealing with addictive behavior. Many prevention programs target age range in school settings, to delay or reduce use of psychoactive substances. A meta-analysis on the impact of this prevention programs in school settings, concluded that most interventions are associated with no or little impact with respect to the goal of reducing psychoactive substances with teenagers. Among existing programs, "PREVENTURE" has been evaluated in 5 trials with high-risk teenagers identified in schools settings, in different countries (Canada, Europe). The results show a clear and robust effect on reducing alcohol consumption. This program has not been tested outside the school setting and a recent review mention the need to make this program more accessible by targeting vulnerable groups and studying the impact of this program on this population. The PREVADO study is a prospective, controlled, randomised, open-label study. After inclusion, the adolescent completes the questionnaire SURPS (Substance Use Risk Profile Scale). The SURPS is self-report questionnaire that assesses four well-validated personality risk factors for substance misuse (Impulsivity, Sensation Seeking, Anxiety Sensitivity, and Hopelessness). There is a 23-item to which adolescents are asked to respond using a 4-point Likert scale ranging from "strongly agree" to "strongly disagree" : Hopelessness (7 items), Anxiety Sensitivity (5 items), Impulsivity (5 items), and Sensation Seeking (6 items). Adolescents will be randomized into 2 groups (stratification on the 4 predominant risk personality types from the SURPS (Substance Use Risk Profile Scale) and on the recruitment modality) : * Intervention group : teenagers follow the "PREVENTURE" program and routine cares * Control group : teenagers follow routine cares

Eligibility Criteria

Inclusion Criteria: * Aged between 14 and 17 years old * Patient consulting in one of the participating centres or referred by a school doctor * Patient who has had at least one previous experience with alcohol (at least 1 standard unit of alcohol, once in their lifetime) * Having access to an internet network and a computer, tablet or telephone * Written and informed consent of the parents and the teenager Exclusion Criteria: * Refusal to participate in the study * Moderate to Severe Adolescent Substance Use Disorders (other than smoking) * Decompensated current psychiatric disorders in adolescents * Already followed for severe use disorders and/or severe psychiatric disorders * Nonunderstanding of the french language

Contact & Investigator

Central Contact

Morgane GUILLOU - LANDREAT, Dr

✉ morgane.guillou@chu-brest.fr

📞 029822342348

Principal Investigator

Morgane GUILLOU - LANDREAT, Dr

PRINCIPAL INVESTIGATOR

CHRU BREST

Frequently Asked Questions

Who can join the NCT04599270 clinical trial?

This trial is open to participants of all sexes, aged 14 Years or older, up to 17 Years, studying Addiction, Alcohol. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT04599270 currently recruiting?

Yes, NCT04599270 is actively recruiting participants. Contact the research team at morgane.guillou@chu-brest.fr for enrollment information.

Where is the NCT04599270 trial being conducted?

This trial is being conducted at Brest, France, Brest, France, Landerneau, France, Morlaix, France and 1 additional location.

Who is sponsoring the NCT04599270 clinical trial?

NCT04599270 is sponsored by University Hospital, Brest. The principal investigator is Morgane GUILLOU - LANDREAT, Dr at CHRU BREST. The trial plans to enroll 700 participants.

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology